Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Congenital Myopathy Intervention Study
2019-001147-51Phase 4Active
- Sponsor
- Region Västra Götaland
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of salbutamol in congenital myopathy (2 arms), sponsored by Region Västra Götaland. Primary endpoint: Motor function measure improvement. Started Sep 2019; status: active.
02
Drugs
salbutamol
03
Conditions
congenital myopathy
Beyond the preview
Go deeper on 2019-001147-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001147-51.